Spots Global Cancer Trial Database for survival outcomes
Every month we try and update this database with for survival outcomes cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer | NCT05311566 | Cervical Carcin... Chemoradiothera... Anti-programmed... Immunotherapy Immune Checkpoi... Survival Outcom... Adverse Events Early Stage Cer... Locally Advance... | Camrelizumab pl... | 18 Years - | Peking Union Medical College Hospital | |
| Donafenib for Recurrent Cervical Cancer | NCT05310331 | Targeted Therap... Chemotherapy Recurrent Cervi... Metastatic Cerv... Persistent Adva... Survival Outcom... Adverse Effect | Donafenib combi... | 18 Years - 75 Years | Peking Union Medical College Hospital | |
| Albumin-bound Paclitaxel and Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer | NCT05310344 | Ovarian Carcino... Platinum-resist... Recurrent Ovari... Albumin-bound P... Bevacizumab Survival Outcom... Adverse Events | Albumin-bound p... | 18 Years - 75 Years | Peking Union Medical College Hospital | |
| Chromosomal Instability in Ovarian Cancer | NCT05310357 | Epithelial Ovar... High-grade Sero... Chromosomal Ins... Somatic Copy Nu... Survival Outcom... Minimal Residua... Progression-fre... Overall Surviva... | Testing for chr... | 18 Years - | Peking Union Medical College Hospital | |
| A Prospective Cohort Study Comparing Disparity in Surgical Procedure (Wide Local Excision Only vs Any Other Surgery Procedures) Among the Elderly Breast Cancer Patients | NCT04426136 | Breast Cancer Elderly Patient Wide Local Exci... Surgery Survival Outcom... | 70 Years - | Peking Union Medical College Hospital | ||
| Chromosomal Instability in Ovarian Cancer | NCT05310357 | Epithelial Ovar... High-grade Sero... Chromosomal Ins... Somatic Copy Nu... Survival Outcom... Minimal Residua... Progression-fre... Overall Surviva... | Testing for chr... | 18 Years - | Peking Union Medical College Hospital | |
| Niraparib Plus Anlotinib for Recurrent Ovarian Cancer | NCT05311579 | Ovarian Carcino... Survival Outcom... Adverse Events Niraparib Anlotinib CA125 Chemotherapy Targeted Therap... Recurrent Ovari... | Niraparib plus ... | 18 Years - | Peking Union Medical College Hospital | |
| An Observational Study of Clinical Treatments for Patients With Oropharyngeal Carcinoma | NCT05341479 | Oropharynx Carc... | Surgery for ear... RT for early-st... CRT for advance... Surgery for adv... Neoadjuvant tre... | 18 Years - 90 Years | Eye & ENT Hospital of Fudan University | |
| NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC | NCT04335669 | Breast Cancer Triple Negative... | epirubicin, cyc... epirubicin, cyc... | 18 Years - 75 Years | Lund University Hospital | |
| A Prospective Cohort Study Comparing Disparity in Surgical Procedure (Wide Local Excision Only vs Any Other Surgery Procedures) Among the Elderly Breast Cancer Patients | NCT04426136 | Breast Cancer Elderly Patient Wide Local Exci... Surgery Survival Outcom... | 70 Years - | Peking Union Medical College Hospital | ||
| Tislelizumab and Radiotherapy for Recurrent Cervical Cancer | NCT05310383 | Recurrent Cervi... Metastatic Cerv... Persistent Cerv... Radiotherapy Immunotherapy Anti-programmed... Immune Checkpoi... Tislelizumab Objective Respo... Survival Outcom... | Tislelizumab pl... | 18 Years - | Peking Union Medical College Hospital | |
| PPIO-007 Correlation Analysis of Type II Diabetes Mellitus on Short-term and Long-term Outcomes of Patients With Esophageal Squamous Cell Cancer Undergoing Minimally Invasive Esophagectomy | NCT06333665 | Esophageal Squa... Surgery | Whether there i... | 18 Years - 80 Years | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | |
| Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma | NCT06281886 | Esophageal Squa... Efficacy Toxicity | Induction Immun... Induction Chemo... Radiotherapy Apatinib Capecitabine | 18 Years - 80 Years | Sun Yat-sen University | |
| Albumin-bound Paclitaxel and Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer | NCT05310344 | Ovarian Carcino... Platinum-resist... Recurrent Ovari... Albumin-bound P... Bevacizumab Survival Outcom... Adverse Events | Albumin-bound p... | 18 Years - 75 Years | Peking Union Medical College Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
